Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 2/20 | 0.48 |
| ▸ | RET | P07949 | 1/20 | 0.45 |
| ▸ | KDR | P35968 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.43 |
| ▸ | MAOB | P27338 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | STK17B | O94768 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28591473 | 0.88 | PARP1 (0.46) | PARP1RETKDRCYP19A1MAOB | |
| SCHEMBL8702376 | 0.79 | ESR1 (0.45) | PARP1RETKDRCYP19A1MAOB | |
| SCHEMBL92288 | 0.79 | ESR1 (0.45) | PARP1RETKDRCYP19A1MAOB | |
| SCHEMBL9434848 | 0.79 | ESR1 (0.45) | PARP1RETKDRCYP19A1MAOB | |
| SCHEMBL67624 | 0.76 | RET (0.41) | PARP1RETKDRCYP19A1MAOB | |
| SCHEMBL31015940 | 0.76 | RET (0.41) | PARP1RETKDRCYP19A1MAOB | |
| SCHEMBL87208 | 0.76 | RET (0.41) | PARP1RETKDRCYP19A1MAOB | |
| SCHEMBL5548145 | 0.76 | RET (0.46) | PARP1RETKDRCYP19A1MAOB | |
| SCHEMBL13928848 | 0.75 | ALDH1A1 (0.46) | RETKDRCYP19A1MAOBKDM4E | |
| SCHEMBL11043870 | 0.75 | ESR1 (0.56) | RETKDRCYP19A1MAOBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1494985-B1 | PRODUCTION AND PURIFICATION OF PHENOL: HYDROXYACETONE REMOVAL BY HYDROTALCITE | SABIC INNOVATIVE PLASTICS IP (NL) | 2014-04-23 | — | — | EP | claimed |
| EP-0372685-B1 | Process for recovering phenol | ENICHEM SPA (IT) | 1995-06-14 | — | — | EP | claimed |
| US-20230348441-A1 | BICYCLIC COMPOUND THAT ACTS AS CRBN PROTEIN REGULATOR | MEDSHINE DISCOVERY INC. (CN) | 2023-11-02 | — | — | US | disclosed |
| US-20230348441-A1 | BICYCLIC COMPOUND THAT ACTS AS CRBN PROTEIN REGULATOR | MEDSHINE DISCOVERY INC. (CN) | 2023-11-02 | — | — | US | disclosed |
| US-20170266167-A1 | ERK INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2017-09-21 | — | — | US | disclosed |
| EP-2053095-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORP (JP) | 2017-02-22 | — | — | EP | disclosed |
| US-9211725-B2 | Inkjet recording method and printed material | FUJIFILM CORPORATION (JP) | 2015-12-15 | — | — | US | disclosed |
| US-9211725-B2 | Inkjet recording method and printed material | FUJIFILM CORPORATION (JP) | 2015-12-15 | — | — | US | disclosed |
| EP-2244984-B1 | REMOVAL OF HYDROCARBONS FROM AN AQUEOUS STREAM | BOREALIS TECH OY (FI) | 2015-03-11 | — | — | EP | disclosed |
| US-8758573-B2 | Removal of hydrocarbons from an aqueous stream | BOREALIS TECHNOLOGY OY (FI) | 2014-06-24 | — | — | US | disclosed |
| EP-2053095-B1 | Ink composition and inkjet recording method using the same | FUJIFILM CORP (JP) | 2014-03-26 | — | — | EP | disclosed |
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090081421-A1 | PHOTOCURABLE COATING COMPOSITION, AND OVERPRINT AND PROCESS FOR PRODUCING SAME | FUJIFILM CORPORATION (JP) | 2009-03-26 | — | — | US | disclosed |
| US-20090081421-A1 | PHOTOCURABLE COATING COMPOSITION, AND OVERPRINT AND PROCESS FOR PRODUCING SAME | FUJIFILM CORPORATION (JP) | 2009-03-26 | — | — | US | disclosed |
| US-20080239045-A1 | INK SET FOR INKJET RECORDING AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
| US-20080239045-A1 | INK SET FOR INKJET RECORDING AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
| US-20080182031-A1 | Sensitizing dye, an alpha-aminoketone or acyl phosphine oxide polymerization initiator and an ethylenically unsaturated bond-containing polymerizable compound | FUJIFILM CORPORATION (JP) | 2008-07-31 | — | — | US | disclosed |
| US-20080182031-A1 | Sensitizing dye, an alpha-aminoketone or acyl phosphine oxide polymerization initiator and an ethylenically unsaturated bond-containing polymerizable compound | FUJIFILM CORPORATION (JP) | 2008-07-31 | — | — | US | disclosed |
| EP-1021431-A1 | METHOD FOR PREPARING OPTIONALLY SUBSTITUTED BENZOFURANONES | BAYER AG (DE) | 2000-07-26 | — | — | EP | disclosed |
| WO-1999019316-A1 | METHOD FOR PREPARING OPTIONALLY SUBSTITUTED BENZOFURANONES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348441-A1 | BICYCLIC COMPOUND THAT ACTS AS CRBN PROTEIN REGULATOR | CRBN, CRKL, NCOR1 | PARP1 4625/4885RET 43/4885KDR 493/4885 |
| US-20170266167-A1 | ERK INHIBITORS | MAPK1, MAPK3, MAPK6 | PARP1 2450/4885RET 262/4885KDR 782/4885 |
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | RB1, IK, NOX1 | PARP1 2522/4885RET 755/4885KDR 2861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.